Alexander Zehnder
Alexander Zehnder is the CEO of Curevac, a German biotech company known for its work on mRNA technology. Recently, he was in the news due to Biontech's announcement of its intention to acquire Curevac in a move aimed at combining their strengths in mRNA research and development.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 7.00 | 0.09% | +0% | 8,654,622 | 7,911 | $700,000 | 640$ |
| Totals | 1 | 8,654,622 | 7,911 | $700,000 | 640$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Alexander Zehnder is the CEO of Curevac, quoted regarding the acquisition by Biontech.
7
Switzerland:
Alexander Zehnder is the CEO of Curevac, who emphasized the significance of the transaction for utilizing mRNA technology.
7